Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse. [electronic resource]
Producer: 20071025Description: 1144-55 p. digitalISSN:- 0016-5085
- Administration, Oral
- Animals
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Drug Evaluation, Preclinical -- methods
- Heart Diseases -- chemically induced
- Hepacivirus -- drug effects
- Hepatitis C -- drug therapy
- Humans
- Liver -- metabolism
- Liver Transplantation
- Macrocyclic Compounds -- administration & dosage
- Mice
- Mice, SCID
- Mice, Transgenic
- Mitochondria, Heart -- drug effects
- Mitochondrial Swelling -- drug effects
- Models, Animal
- Myocytes, Cardiac -- drug effects
- Protease Inhibitors -- administration & dosage
- Quinolines -- administration & dosage
- Thiazoles -- administration & dosage
- Time Factors
- Transplantation, Heterologous
- Urokinase-Type Plasminogen Activator -- blood
- Viral Load
- Viral Nonstructural Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.